Owkin

Owkin is a company founded in 2016 headquartered in France. Its most recent tracked round is Series-c-plus. Brouky records 4 investors associated with the company.

Owkin is a French-American company that leverages artificial intelligence and federated learning to accelerate drug discovery and development. They partner with pharmaceutical companies and academic research centers to unlock insights from medical research data, particularly in oncology.